Breaking News Instant updates and real-time market news.

BEAT

BioTelemetry

$59.26

0.52 (0.89%)

16:22
04/25/19
04/25
16:22
04/25/19
16:22

BioTelemetry reports Q1 EPS 42c, consensus 42c

Reports Q1 revenue $104M, consensus $104.1M. Joseph H. Capper, President and Chief Executive Officer of BioTelemetry, Inc., commented: "The first quarter was another great quarter with record revenue and a strong adjusted EBITDA margin, both of which were in line with our expectations. Demand for our services remained strong with MCT and extended Holter services driving patient volume growth as well as a 9% increase in Healthcare revenue. Additionally, our Research division posted double-digit revenue growth while our digital population health business benefitted from the launch of a significant new managed care partnership. "During the quarter, we completed the acquisition of Geneva Healthcare, extending our remote cardiac monitoring reach into the $1 billion implantable cardiac monitoring market. We believe this transaction further reinforces our growth strategy and provides significant revenue upside for the company. Our excitement about Geneva continues to grow based on its early performance and the tremendous interest being generated from our top customers. We expect the combination of the benefits from the Geneva platform and our unmatched portfolio of remote cardiac monitoring services to further solidify our leadership position in cardiac monitoring.

  • 25

    Apr

  • 02

    May

  • 07

    May

BEAT BioTelemetry
$59.26

0.52 (0.89%)

04/02/19
BNCH
04/02/19
NO CHANGE
Target $82
BNCH
Buy
BioTelemetry pullback on iRhythm concerns a buying opportunity, says Benchmark
Benchmark analyst Bill Sutherland attributes recent weakness in shares of BioTelemetry (BEAT) to a short thesis on competitor iRhythm (IRTC) that was released in late March that makes "a strong case" for the potential of a sharp drop in reimbursement for the technical service on extended wear holters after 2021. BioTelemetry, unlike iRhythm, has just introduced its extended wear holter and that product only makes up about 1% of BioTelemetry's total revenue by his estimates, Sutherland tells investors. The analyst, who doesn't see a reimbursement change materially impacting BioTelemetry's long-term revenue growth, keeps a Buy rating and $82 price target on the shares, calling the selloff a buying opportunity.
03/27/19
JPMS
03/27/19
NO CHANGE
JPMS
Overweight
iRhythm reimbursement worries remain unfounded, says JPMorgan
JPMorgan analyst Robbie Marcus noted that two separate short reports on iRhythm (IRTC) have been published this week, but he believes the arguments made in both are "unfounded and based upon false premises." The most recent short report asserts that competitor BioTelemetry (BEAT) is pushing for the American College of Cardiology to lower reimbursement or open up the Category III code earlier, but Marcus believe it is unlikely that a competitor could push the ACC to negotiate for lower reimbursement or a move to a new code ahead of schedule. He views today's report as "a slightly different take on the same flawed argument made by previous short reports," and would be a buyer of iRhythm shares amid the weakness. Marcus keeps an Overweight rating on iRhythm and reiterated the stock as a Top Pick.
02/22/19
LSCM
02/22/19
NO CHANGE
Target $90
LSCM
Buy
BioTelemetry 'executed beautifully on all fronts,' says Lake Street
BioTelemetry "executed beautifully on all fronts" in Q4 and during 2018 and its outlook for 2019 is strong, Lake Street analyst Brooks O'Neil tells investors in a post-earnings research note. The analyst believes remote patient monitoring is in its infancy and that BioTelemetry is the leader in this "exciting space." He affirms his Buy rating on the shares with a $90 price target.
01/03/19
BNCH
01/03/19
NO CHANGE
BNCH
Activision, Canopy Growth among Best Ideas for first half of 2019 at Benchmark
Benchmark analysts selected their Best Ideas for the first half of 2019, naming 16 stocks, including: Activision Blizzard (ATVI), BioTelemetry (BEAT), Biofrontera (BFRA), Ctrip (CTRP), Huazhu Group (HTHT), II-VI (IIVI), Intevac (IVAC), LHC Group (LHCG), Meredith (MDP), Marvell (MRVL), NeoGenomics (NEO), Pegasystems (PEGA), Silicon Labs (SLAB), Varonis (VRNS), Canopy Growth (CGC) and Waitr Holdings (WTRH).

TODAY'S FREE FLY STORIES

WM

Waste Management

$117.15

0.39 (0.33%)

17:12
07/22/19
07/22
17:12
07/22/19
17:12
Initiation
Waste Management initiated  »

Waste Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

IBTX

Independent Bank

$55.08

-1.08 (-1.92%)

17:05
07/22/19
07/22
17:05
07/22/19
17:05
Earnings
Independent Bank reports Q2 adjusted EPS $1.22, consensus $1.27 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 26

    Aug

  • 23

    Sep

RNST

Renasant

$34.10

-0.49 (-1.42%)

17:04
07/22/19
07/22
17:04
07/22/19
17:04
Earnings
Renasant reports Q2 EPS 80c with items, consensus 81c »

Reports Q2 net loan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 23

    Sep

STLD

Steel Dynamics

$31.55

0.09 (0.29%)

17:03
07/22/19
07/22
17:03
07/22/19
17:03
Hot Stocks
Steel Dynamics announces planned new flat roll steel mill site selection »

Steel Dynamics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 06

    Aug

BRO

Brown & Brown

$34.64

-0.11 (-0.32%)

17:02
07/22/19
07/22
17:02
07/22/19
17:02
Hot Stocks
Brown & Brown reports Q2 organic revenue up 3.9% »

Reports Q2 EBITDA margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

HAE

Haemonetics

$122.44

0.35 (0.29%)

17:02
07/22/19
07/22
17:02
07/22/19
17:02
Hot Stocks
Haemonetics updates financial reporting segments »

Haemonetics Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 06

    Aug

  • 05

    Sep

  • 09

    Sep

BRO

Brown & Brown

$34.64

-0.11 (-0.32%)

17:01
07/22/19
07/22
17:01
07/22/19
17:01
Earnings
Brown & Brown reports Q2 adjusted EPS 32c, consensus 28c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

DLX

Deluxe

$41.95

0.41 (0.99%)

17:00
07/22/19
07/22
17:00
07/22/19
17:00
Hot Stocks
Deluxe names Chris Thomas chief revenue officer »

Deluxe Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 19

    Sep

GE

General Electric

$10.22

0.18 (1.79%)

, AVCO

Avalon GloboCare

$2.05

-0.105 (-4.88%)

16:57
07/22/19
07/22
16:57
07/22/19
16:57
Hot Stocks
Avalon GloboCare and GE Healthcare announce strategic partnership »

Avalon GloboCare (AVCO)…

GE

General Electric

$10.22

0.18 (1.79%)

AVCO

Avalon GloboCare

$2.05

-0.105 (-4.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 09

    Sep

  • 09

    Sep

VIVE

Viveve

$0.41

-0.0155 (-3.68%)

16:55
07/22/19
07/22
16:55
07/22/19
16:55
Hot Stocks
Breaking Hot Stocks news story on Viveve 

Viveve trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VFF

Village Farms

$10.69

0.48 (4.70%)

16:53
07/22/19
07/22
16:53
07/22/19
16:53
Initiation
Village Farms initiated  »

Village Farms initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBY

Best Buy

$75.72

0.995 (1.33%)

16:53
07/22/19
07/22
16:53
07/22/19
16:53
Hot Stocks
Best Buy beneficial owner Richard Schulze sells $32.4M in company shares »

Best Buy beneficial owner…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

ORGO

Organogenesis

$5.85

-0.27 (-4.41%)

16:50
07/22/19
07/22
16:50
07/22/19
16:50
Syndicate
Organogenesis commences exchange offer »

Organogenesis Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

WD

Walker & Dunlop

$55.46

-0.39 (-0.70%)

16:49
07/22/19
07/22
16:49
07/22/19
16:49
Hot Stocks
Walker & Dunlop appoints Chief Production Officer to Lead FHA finance team »

Walker & Dunlop…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 15

    Aug

EQBK

Equity Bancshares

$24.43

-0.19 (-0.77%)

16:49
07/22/19
07/22
16:49
07/22/19
16:49
Earnings
Equity Bancshares reports Q2 EPS 58c, consensus 60c »

The net interest margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 23

    Sep

RPAY

Repay Holdings

$11.51

-0.26 (-2.21%)

16:47
07/22/19
07/22
16:47
07/22/19
16:47
Hot Stocks
Monroe Capital reports 6.5% passive stake in Repay Holdings »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

TRWH

Twin River Worldwide

$28.10

0.1 (0.36%)

16:45
07/22/19
07/22
16:45
07/22/19
16:45
Hot Stocks
Twin River Worldwide extends tender offer expiration time to July 26 »

Twin River Worldwide…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRWH

Twin River Worldwide

$28.10

0.1 (0.36%)

16:44
07/22/19
07/22
16:44
07/22/19
16:44
Earnings
Twin River Worldwide reports preliminary Q2 revenue $146.5M-$148.5M »

Consensus $161.33M.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFX

Equifax

$137.84

0.55 (0.40%)

, MU

Micron

$47.21

1.7 (3.74%)

16:43
07/22/19
07/22
16:43
07/22/19
16:43
On The Fly
Fly Intel: Wall Street's top stories for Monday »

Stocks rose as earnings…

EFX

Equifax

$137.84

0.55 (0.40%)

MU

Micron

$47.21

1.7 (3.74%)

MTN

Vail Resorts

$235.48

9.665 (4.28%)

SKIS

Peak Resorts

$10.85

5.71 (111.09%)

FB

Facebook

$202.32

3.94 (1.99%)

INTC

Intel

$51.36

1.1 (2.19%)

AVGO

Broadcom

$296.11

6.06 (2.09%)

GOOG

Alphabet

$1,138.09

8.09 (0.72%)

GOOGL

Alphabet Class A

$1,139.52

7.85 (0.69%)

BX

Blackstone

$47.81

2.18 (4.78%)

CQP

Cheniere Energy Partners

$43.96

0.835 (1.94%)

BYND

Beyond Meat

$193.91

17.26 (9.77%)

HAL

Halliburton

$23.76

2.02 (9.29%)

PAYS

Paysign

$13.68

-3.81 (-21.78%)

CADE

Cadence Bancorp

$15.86

-3.75 (-19.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 22

    Jul

  • 24

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 29

    Jul

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

  • 12

    Aug

  • 26

    Aug

  • 27

    Aug

  • 23

    Sep

  • 26

    Sep

  • 27

    Oct

  • 13

    Nov

ACAD

Acadia

$25.97

0.28 (1.09%)

16:36
07/22/19
07/22
16:36
07/22/19
16:36
Hot Stocks
Breaking Hot Stocks news story on Acadia »

Acadia down over 16% at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 20

    Aug

ACAD

Acadia

$25.97

0.28 (1.09%)

16:35
07/22/19
07/22
16:35
07/22/19
16:35
Hot Stocks
Breaking Hot Stocks news story on Acadia 

Acadia trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 20

    Aug

FULC

Fulcrum Therapeutics

$12.84

0.35 (2.80%)

16:34
07/22/19
07/22
16:34
07/22/19
16:34
Hot Stocks
Fulcrum Therapeutics chairman Mark Levin buys $1.3M in company shares »

Fulcrum Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$105.66

-1.35 (-1.26%)

16:34
07/22/19
07/22
16:34
07/22/19
16:34
Earnings
Celanese still sees 'path to' FY19 EPS of $10.50, consensus $10.20 »

CEO Lori Ryerkerk says:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

FTI

TechnipFMC

$25.61

0.5 (1.99%)

16:33
07/22/19
07/22
16:33
07/22/19
16:33
Hot Stocks
TechnipFMC awarded iEPCI contract from Neptune Energy for Seagull project »

TechnipFMC has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 27

    Aug

CE

Celanese

$105.66

-1.35 (-1.26%)

16:33
07/22/19
07/22
16:33
07/22/19
16:33
Hot Stocks
Celanese reports Q2 operating EBITDA $458M vs. $573M last year »

Reports Q2 free cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.